A randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2009
At a glance
- Drugs Sorafenib; Temozolomide
- Indications Malignant melanoma
- Focus Pharmacogenomic; Therapeutic Use
- 15 Dec 2009 Results have been published in the journal Clinical Cancer Research.
- 15 Dec 2009 Status changed from active, no longer recruiting to completed. According to results published in the journal Clinical Cancer Research.
- 14 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History